Insights into the Development of Preneoplastic Metaplasia: Spasmolytic Polypeptide-Expressing Metaplasia and Oxyntic Atrophy

  • James R. Goldenring
  • Sachiyo Nomura


Deaths from gastric adenocarcinoma are the third largest cause of cancer-related mortality in the world (Pisani et al. 1999). Early recognition and resection of gastric cancers remains the mainstay of gastric cancer therapy, and adjuvant treatment regimens provide only minimal benefits beyond surgery (Wainess et al. 2003). Although aggressive endoscopic screening procedures in Asian countries, such as Japan and South Korea, have led to earlier discovery and surgical removal of gastric cancers (Rembacken et al. 2001), little is known of the cellular etiology of gastric neoplasms. Although the concept of preneoplasia does spur screening endoscopy, there is a general lack of knowledge of the sequence of events leading first to metaplasia and later to preneoplastic lesions and gastric cancer. This uncertainty in the analysis of precancerous events hobbles efforts to develop effective screening methods for patient populations at risk for gastric cancer. Thus, detailed analyses...


Gastric Cancer Intestinal Metaplasia Parietal Cell Fundic Gland Mucosal Lineage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Biankin, A.V., J.G. Kench, F.P. Dijkman, S.A. Biankin, and S.M. Henshall. 2003. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma. Pathology. 35:14–24.CrossRefPubMedGoogle Scholar
  2. Blaser, M. 1992. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology. 102:720–727.PubMedGoogle Scholar
  3. Blaser, M., and J. Parsonnet. 1994. Parasitism by the ‘slow’ bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest. 94:4–8.CrossRefPubMedGoogle Scholar
  4. Borch, K., H. Renvall, and G. Liedberg. 1985. Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology. 88:638–648.PubMedGoogle Scholar
  5. Brito, M.J., M.I. Filipe, J. Linehan, and J. Jankowski. 1995. Association of transforming growth factor alpha (TGFA) and its precursors with malignant change in Barrett's epithelium: biological and clinical variables. Int J Cancer. 60:27–32.CrossRefPubMedGoogle Scholar
  6. Burdick, J.S., E. Chung, G. Tanner, M. Sun, J.E. Paciga, J.Q. Cheng, K. Washington, J.R. Goldenring, and R.J. Coffey. 2000. Treatment of Menetrier's disease with a monoclonal antibody against the epidermal growth factor receptor. N Engl J Med. 343:1697–1701.CrossRefPubMedGoogle Scholar
  7. Cameron, A.J., C.T. Lomboy, M. Pera, and H.A. Carpenter. 1995. Adenocarcinoma of the esoph-agogastric junction and Barrett's esophagus. Gastroenterology. 109:1541–1546.CrossRefPubMedGoogle Scholar
  8. Cameron, A.J., B.J. Ott, and W.S. Payne. 1985. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. New Engl J Med. 313:857–859.CrossRefPubMedGoogle Scholar
  9. Canfield, V.A., A.B. West, J.R. Goldenring, and R. Levenson. 1996. Targeted ablation of parietal cells in transgenic mice. Proc Natl Acad Sci USA. 93(6):2431–2435.CrossRefPubMedGoogle Scholar
  10. Coffey, R.J., R. Derynck, J.N. Wilcox, T.S. Bringman, A.S. Goustin, H.L. Moses, and M.R. Pittelkow. 1987. Production and auto-induction of TGF alpha in human keratinocytes. Nature. 328:817–820.CrossRefPubMedGoogle Scholar
  11. Correa, P. 1988. A human model of gastric carcinogenesis. Cancer Res. 48:3554–3560.PubMedGoogle Scholar
  12. Courtois-Coutry, N., D. Rousch, V. Rajendran, J.B. McCarthy, J. Geibel, M. Kashgarian, and M.J. Caplan. 1997. A tyrosine-based signal targets H/K-ATPase to a regulated compartment and is required for the cessation of gastric acid secretion. Cell. 90:501–510.CrossRefPubMedGoogle Scholar
  13. Dempsey, P.J., J.R. Goldenring, C.J. Soroka, I.M. Modlin, R.W. McClure, C.D. Lind, D.A. Ahlquist, M.R. Pittlekow, D.C. Lee, E.P. Sandgren, D.L. Page, and R.J. Coffey. 1992. Possible role of TGFa in the pathogenesis of Menetrier's disease: supportive evidence from humans and transgenic mice. Gastroenterology. 103:1950–1963.PubMedGoogle Scholar
  14. Dhar, D.K., T.C. Wang, R. Maruyama, J. Udagawa, H. Kubota, T. Fuji, M. Tachibana, T. Ono, H. Otani, and N. Nagasue. 2003. Expression of cytoplasmic TFF2 is a marker of tumor metastasis and negative prognostic factor in gastric cancer. Lab Invest. 83:1343–1352.CrossRefPubMedGoogle Scholar
  15. El-Zimaity, H.M.T., H. Ota, D.Y. Graham, T. Akamatsu, and T. Katsuyama. 2002. Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer. 94:1428–1436.CrossRefPubMedGoogle Scholar
  16. Filipe, M.I., N. Munoz, I. Matko, I. Kato, V. Pompe-Kirn, A. Juersek, S. Teuchmann, M. Benz, and T. Prijon. 1994. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer. 57:324–329.CrossRefPubMedGoogle Scholar
  17. Fox, J.G., M. Blanco, J.C. Murphy, N.S. Taylor, A. Lee, Z. Kabok, and J. Pappo. 1993. Local and systemic immune responses in murine Helicobacter felis active chronic gastritis. Infect Immun. 61:2309–2315.PubMedGoogle Scholar
  18. Fox, J.G., X. Li, R.J. Cahill, K. Andrutis, A.K. Rustgi, R. Odze, and T.C. Wang. 1996. Hypertrophic gastropathy in Helicobacter felis-infected wild type C57BL/6 mice and p53 hemizygous transgenic mice. Gastroenterology. 110:155–166.CrossRefPubMedGoogle Scholar
  19. Fox, J.G., T.C. Wang, A.B. Rogers, T. Poutahidis, Z. Ge, N. Taylor, C.A. Dangler, D.A. Israel, U. Krishna, K. Gaus, and R.M. Peek, Jr. 2003. Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology. 124:1879–1890.CrossRefPubMedGoogle Scholar
  20. Goldenring, J.R., and S. Nomura. 2006. Differentiation of the gastric mucosa III. Animal models of oxyntic atrophy and metaplasia. Am J Physiol Gastrointest Liver Physiol. 291:G999–1004.CrossRefPubMedGoogle Scholar
  21. Goldenring, J.R., G.S. Ray, R.J. Coffey, P.C. Meunier, P.J. Haley, T.B. Barnes, and B.D. Car. 2000. Reversible drug-induced oxyntic atrophy in rats. Gastroenterology. 118:1080–1093.CrossRefPubMedGoogle Scholar
  22. Halldorsdottir, A.M., M. Sigurdardottir, J.G. Jonasson, M. Oddsdottir, J. Magnusson, J.R. Lee, and J.R. Goldenring. 2003. Spasmolytic polypeptide expressing metaplasia (SPEM) associated with gastric cancer in Iceland. Dig Dis Sci. 48:431–441.CrossRefPubMedGoogle Scholar
  23. Hattori, T. 1986. Development of adenocarcinomas in the stomach. Cancer. 57:1528–1534.CrossRefPubMedGoogle Scholar
  24. Hattori, T., and S. Fujita. 1979. Tritiated thymidine autoradiographic study on histogenesis and spreading of intestinal metaplasia in human stomach. Pathol Res Pract. 164:224–237.PubMedGoogle Scholar
  25. Hattori, T., B. Helpap, and P. Gedigk. 1982. The morphology and cell kinetics of pseudopyloric glands. Virchows Arch B Cell Pathol Incl Mol Pathol. 39:31–40.CrossRefPubMedGoogle Scholar
  26. Houghton, J., C. Stoicov, S. Nomura, J. Carlson, H. Li, A.B. Rogers, J.G. Fox, J.R. Goldenring, and T.C. Wang. 2004. Gastric cancer originating from bone marrow derived cells. Science. 306:1568–1571.CrossRefPubMedGoogle Scholar
  27. Katz, J.P., N. Perreault, B.G. Goldstein, L. Actman, S.R. McNally, D.G. Silberg, E.E. Furth, and K.H. Kaestner. 2005. Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology. 128:935–945.CrossRefPubMedGoogle Scholar
  28. Kirchner, T., S. Muller, T. Hattori, K. Mukaisyo, T. Papadopoulos, T. Brabletz, and A. Jung. 2001. Metaplasia, intraepithelial neoplasia and early cancer of the stomach are related to dedifferentiated epithelial cells defined by cytokeratin-7 expression in gastritis. Virchows Arch. 439:512–522.CrossRefPubMedGoogle Scholar
  29. Konda, Y., H. Kamimura, H. Yokota, N. Hayashi, K. Sugano, and T. Takeuchi. 1999. Gastrin stimulates the growth of gastric pit with less-differentiated features. Am J Physiol. 277: G773–784.PubMedGoogle Scholar
  30. Leys, C.M., S. Nomura, E. Rudzinski, M. Kaminishi, E. Montgomery, M.K. Washington, and J.R. Goldenring. 2006. Expression of Pdx-1 in human gastric metaplasia and gastric adenocar-cinoma. Hum Pathol. 37:1162–1168.CrossRefPubMedGoogle Scholar
  31. Li, Q., S.M. Karam, and J.I. Gordon. 1996. Diphtheria toxin-mediated ablation of parietal cells in the stomach of transgenic mice. J Biol Chem. 271:3671–3676.CrossRefPubMedGoogle Scholar
  32. Lopez-Diaz, L., K.L. Hinkle, R.N. Jain, Y. Zavros, C.S. Brunkan, T. Keeley, K.A. Eaton, J.L. Merchant, C.S. Chew, and L.C. Samuelson. 2006. Parietal cell hyperstimulation and autoimmune gastritis in cholera toxin transgenic mice. Am J Physiol Gastrointest Liver Physiol. 290: G970–979.CrossRefPubMedGoogle Scholar
  33. Marshall, A.C., F. Alderuccio, K. Murphy, and B.H. Toh. 2005. Mechanisms of gastric mucosal cell loss in autoimmune gastritis. Int Rev Immunol. 24:123–134.CrossRefPubMedGoogle Scholar
  34. Means, A.L., I.M. Meszoely, K. Suzuki, Y. Miyamoto, A.K. Rustgi, R.J. Coffey, Jr., C.V. Wright, D.A. Stoffers, and S.D. Leach. 2005. Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development.132:3767–3776.CrossRefPubMedGoogle Scholar
  35. Mutoh, H., Y. Hakamata, K. Sato, A. Eda, I. Yanaka, S. Honda, H. Osawa, Y. Kaneko, and K. Sugano. 2002. Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. Biochem Biophys Res Commun. 294:470–479.CrossRefPubMedGoogle Scholar
  36. Nam, K.T., A. Varro, R.J. Coffey, and J.R. Goldenring. 2007. Potentiation of oxyntic atrophy-induced gastric metaplasia in amphiregulin-deficient mice. Gastroenterology. 132:1804–1819.CrossRefPubMedGoogle Scholar
  37. Nomura, S., S.H. Settle, C. Leys, A.L. Means, R.M. Peek, Jr., S.D. Leach, C.V.E. Wright, R.J. Coffey, and J.R. Goldenring. 2005. Evidence for repatterning of the gastric fundic epithelium associated with Menetrier's disease and TGFa overexpression. Gastroenterology. 128:1292–1305.CrossRefPubMedGoogle Scholar
  38. Nomura, S., H. Yamaguchi, T.C. Wang, J.R. Lee, and J.R. Goldenring. 2004. Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild type and gastrin deficient mice. Am J Physiol. 288:G362–G375.Google Scholar
  39. Nozaki, K., M. Ogawa, J.A. Williams, B.J. LaFleur, V. Ng, R.I. Drapkin, J.C. Mills, S.F. Konieczny, S. Nomura, and J.R. Goldenring. 2008. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss. Gastroenterology. 134(2):511–522.CrossRefPubMedGoogle Scholar
  40. Ogawa, T., K. Maeda, S. Tonai, T. Kobayashi, T. Watanabe, and S. Okabe. 2003. Utilization of knockout mice to examine the potential role of gastric histamine H2-receptors in Menetrier's disease. J Pharmacol Sci. 91:61–70.CrossRefPubMedGoogle Scholar
  41. Ogawa, M., S. Nomura, B.D. Car, and J.R. Goldenring. 2006a. Omeprazole treatment ameliorates oxyntic atrophy induced by DMP-777. Dig Dis Sci. 51:431–439.CrossRefGoogle Scholar
  42. Ogawa, M., S. Nomura, A. Varro, T.C. Wang, and J.R. Goldenring. 2006b. Altered metaplastic response of waved-2 EGF receptor mutant mice to acute oxyntic atrophy. Am J Physiol Gastrointest Liver Physiol. 290:G793–804.CrossRefGoogle Scholar
  43. Ormand, J.E., N.J. Talley, R.G. Shorter, C.R. Conley, H.A. Carpenter, A. Fich, W.R. Wilson, and S.F. Phillips. 1991. Prevalence of Helicobacter pylori in specific forms of gastritis: further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci. 36:142–145.CrossRefPubMedGoogle Scholar
  44. Oshima, M., H. Oshima, A. Matsunaga, and M.M. Taketo. 2005. Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 trans-genic mice. Cancer Res. 65:9147–9151.CrossRefPubMedGoogle Scholar
  45. Parsonnet, J., G.D. Friedman, D.P. Vandersteen, Y. Chang, J.H. Vogelman, N. Orentreich, and R.K. Sibley. 1991. Helicobacter pylori infection and the risk of gastric cancer. New Engl J Med. 325:1127–1131.CrossRefPubMedGoogle Scholar
  46. Peura, D.A. 1997. The report of the Digestive Health Initiative international update conference on Helicobacter pylori. Gastroenterology. 113:S4–S8.Google Scholar
  47. Pisani, P., D.M. Parkin, F. Bray, and J. Ferlay. 1999. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 83:18–29.CrossRefPubMedGoogle Scholar
  48. Rembacken, B., T. Fujii, and H. Kondo. 2001. The recognition and endoscopic treatment of early gastric and colonic cancer. Best Pract Res Clin Gastroenterol. 15:317–336.CrossRefPubMedGoogle Scholar
  49. Schmidt, P.H., J.R. Lee, V. Joshi, R.J. Playford, R. Poulsom, N.A. Wright, and J.R. Goldenring. 1999. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest. 79:639–646.PubMedGoogle Scholar
  50. Sharp, R., M.W. Babyatsky, H. Takagi, S. Tagerud, T.C. Wang, D.E. Bockman, S.E. Brand, and G. Merlino. 1995. Transforming growth factor alpha disrupts the normal program of cellular differentiation in the gastric mucosa of transgenic mice. Development. 121:149–161.PubMedGoogle Scholar
  51. Silberg, D.G., J. Sullivan, E. Kang, G.P. Swain, J. Moffett, N.J. Sund, S.D. Sackett, and K.H. Kaestner. 2002. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology. 122:689–696.CrossRefPubMedGoogle Scholar
  52. Takizawa, T., and M. Koike. 1998. Minute gastri carcinoma from pathomorphological aspect— reconsideration concerning histogenesis of gastric carcinomas. Stomach Intestine. 23:791–800.Google Scholar
  53. Wainess, R.M., J.B. Dimick, G.R. Upchurch, Jr., J.A. Cowan, and M.W. Mulholland. 2003. Epidemiology of surgically treated gastric cancer in the United States, 1988–2000. J Gastrointest Surg. 7:879–883.PubMedGoogle Scholar
  54. Wang, T.C., C.A. Dangler, D. Chen, J.R. Goldenring, T. Koh, R. Raychowdhury, R.J. Coffey, S. Ito, A. Varro, G.J. Dockray, and J.G. Fox. 2000. Synergistic interaction between hypergas-trinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology. 118:36–47.CrossRefPubMedGoogle Scholar
  55. Wang, T.C., J.R. Goldenring, C. Dangler, S. Ito, A. Mueller, W.K. Jeon, T.J. Koh, and J.G. Fox. 1998. Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection. Gastroenterology. 114:675–689.CrossRefPubMedGoogle Scholar
  56. Wolfsen, H.C., H.A. Carpenter, and N.J. Talley. 1993. Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology. 104:1310–1319.PubMedGoogle Scholar
  57. Wright, N.A., C. Pike, and G. Elia. 1990. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature. 343:82–85.CrossRefPubMedGoogle Scholar
  58. Xia, H.H., J.S. Kalantar, N.J. Talley, J.M. Wyatt, S. Adams, K. Cheung, and H.M. Mitchell. 2000.Antral-type mucosa in the gastric incisura, body and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia. Am J Gastroenterol. 95:114–121.CrossRefPubMedGoogle Scholar
  59. Yamaguchi, H., J.R. Goldenring, M. Kaminishi, and J.R. Lee. 2001. Identification of spasmolytic polypeptide expressing metaplasia (SPEM) in remnant gastric cancer and surveillance post-gastrectomy biopsies. Dig Dis Sci. 47:573–578.CrossRefGoogle Scholar
  60. Yamaguchi, H., J.R. Goldenring, M. Kaminishi, and J.R. Lee. 2002. Association of spasmolytic polypeptide expressing metaplasia (SPEM) with carcinogen administration and oxyntic atrophy in rats. Lab Invest. 82:1045–1052.PubMedGoogle Scholar
  61. Yoshizawa, N., Y. Takenaka, H. Yamaguchi, T. Tetsuya, H. Tanaka, M. Tatematsu, S. Nomura, J.R. Goldenring, and M. Kaminishi. 2007. Emergence of spasmolytic polypeptide-expressing metaplasia in Mongolian gerbils infected with Helicobacter pylori. Lab Invest. 87:1265–1276.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2009

Authors and Affiliations

  • James R. Goldenring
    • 1
  • Sachiyo Nomura
    • 2
  1. 1.Nashville Department of Veterans Affairs Medical CenterNashvilleUSA
  2. 2.Department of Gastrointestinal SurgeryGraduate School of Medicine, University of TokyoTokyoJapan

Personalised recommendations